American Well Corporation Class A (AMWL) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello, everyone, and welcome to Amwell's conference call to discuss their fourth fiscal quarter and full year 2025. Joining us on the call today are Amwell's chairman and CEO, Dr. Ido Schoenberg, and Mark Hirshhorn, Amwell's CFO and chief operating officer. Earlier today, a press release was distributed detailing their announcement. The earnings report is posted on the Amwell website at investors.amwell.com, and it's also available through normal news sources. This conference call is being webcast live on the IR page of the website, where a replay will be archived. Before they begin prepared remarks, I'd like to take this opportunity to remind you that during the call, we will make forward-looking statements regarding projected operating results and anticipated market opportunities. This forward-looking information is subject to risk and uncertainty as described in the filings with the SEC. Actual results or events may differ materially. Except as required by law, we undertake no obligation to update or revise these four looking statements. On this call, we'll refer to both GAAP and non-GAAP financial measures. A reconciliation of GAAP to non-GAAP financial measures is provided in the earnings release. With that, I would like to turn the call over to Ido. Thank you, Operator, and good afternoon, everyone. 2025 was a pivotal year for Armwell. We sharpened our focus, executed a major transformation, and entered 2026 with clear visibility towards the goal of cash flow breakeven from operations in Q4. Today, I'll cover three areas. The market trends driving our strategy, our 2025 execution highlights, and our plan for 2026. Mark will then walk you through our detailed financial and guidance. After that, we'll take your questions. The healthcare landscape entering 2026 is...